New approaches in the battle against heartworm disease
Heartworm disease is a concern to dog and cat owners worldwide. Current disease control methods are increasingly challenged by drug resistance. Read more.
Search
EMPRISE
Learn about the EMPRISE real-world evidence study and use of empagliflozin in routine clinical care. Click here to find out more information.
COVID-19 Boehringer Ingelheim Clinical Trials
We are doing everything we can to limit the impact COVID-19 could have on our clinical trial programs. Click here to find out and learn more.
Patient Safety
Patient Safety@ Boehringer Ingelheim Pharmacovigilance
COVID-19 Message from Jean Scheftsik de Szolnok
Click here to watch and hear a message from Jean Scheftsik de Szolnok, Head of the Animal Health Business Unit, Boehringer Ingelheim. Learn more here.
History video
The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer in Nieder-Ingelheim. Watch the video here to learn more.
COVID-19 KSA applauds to HCPs
The Boehringer Ingelheim Saudi Arabia team would like to thank all doctors for their hard work. Click here to find out and learn more information.
My.Making More Health Website
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
Boehringer Ingelheim India enters into second collaboration with SIIC IIT Kanpur to support healthcare innovation
COVID-19 Psychological support for HCPs
Boehringer Ingelheim Spain offers psychological support to health professionals in order to take care of their emotional health in these difficult times.
Solidarity with Ukraine
Our company condemns the military aggression against Ukraine and is committed to helping those in need in the longer term. Click here to learn more.
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Patient voices Ulrichs story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Ulrich's story.
Patient voices Eves story
‘Telling My Story’ is a video series featuring stories from patients from across the world with AF, DVT and PE. Click here to hear Eve's story.
Patient voices Augustos story
Hear from patients and families on how atrial fibrillation (AF), deep vein thrombosis (DVT) and pulmonary embolism (PE) have affected their lives.
Driving Innovation through Diversity & Inclusion
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Telling my story AF and DVT PE Patient Voices
Telling My Story is a video series featuring stories from across the world from patients with AF, DVT, and PE. Click here to hear their stories.
Transboundary and emerging diseases
We fight TEDs through cutting-edge technologies. Click here to find out how our colleagues in Global Innovation and VPH prepare for outbreaks.
The Angels Initiative – F.A.S.T.
Recognise the symptoms of stroke and seek immediate medical help to improve outcomes. Click here to learn more and find out more information.
Pet industry trends Millennials
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
Imprint
Here you can access contact details and information about Boehringer Ingelheim International GmbH. Click here to find out and learn more information.
World Heart Day 2021
The heart is one of the things with the potential to unite all of us as people. Click here to read patient stories about their heartbeat moment.
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Boehringer Ingelheim introduces NexGard SPECTRA® for dogs in India
Resizing our Carbon Footprint
The ecological balance of the world is at a tipping point. Thus, we step up the initiative “Carbon Footprint”. Click here to find out more information.
Vision & Values
Boehringer Ingelheim objectives and beliefs can be summed up in a single phrase: value through Innovation, the central concept of our corporate vision.